Реактин

Quick links

Choose a section

Quick links to important sections

Advertisements

Реактин

Advertisements
Advertisements

Overview of Реактин

Quick Facts about Реактин (Levocabastine)

Property Description
Active ingredient Levocabastine hydrochloride
Form Ophthalmic suspension, Nasal spray
Pharmacological class Selective Histamine H1-receptor antagonist
Common purpose Relief of localized allergic symptoms
Origin Synthetic (Piperidine derivative)

What Type of Medicine is Реактин (Levocabastine)?

Реактин is an antiallergic medicinal preparation containing the active ingredient Levocabastine hydrochloride, a compound developed as a highly selective second-generation Histamine H1-receptor antagonist. This classification confirms its design for targeted action against immediate allergic mediators. The Levocabastine compound is a synthetic organic molecule derived from the piperidines chemical class.

A key differentiating feature of Реактин is its strictly topical use profile, available as an ophthalmic suspension (eye drops) and a nasal spray. This microsuspension formulation ensures maximum local concentration of the active substance while minimizing systemic absorption. Its focused action is integral to its role as a topical antiallergic agent.

How Does the Active Ingredient Levocabastine Work?

The general purpose of Реактин is realized through selective histamine blocking, where Levocabastine functions as an antagonist, binding competitively and with high affinity to the H1-receptors. This mechanism effectively prevents the binding of histamine—the primary chemical released during allergic sensitization—thereby halting the allergic cascade before it escalates.

This mechanism of effect provides fast-acting localized topical action, a crucial factor when immediate intervention is required, such as during sudden exposure to environmental or seasonal allergens. The targeted approach of the drug offers prompt relief from the symptoms associated with the excessive histamine release in the eyes and nose.

Advertisements

What side effects are possible with Реактин?

Possible side effects and safety information

The safety profile for Реактин (Levocabastine), documented in official regulatory sources, primarily involves localized reactions consistent with its topical use as an ophthalmic suspension and nasal spray, alongside a classification of rare systemic effects.

Adverse reactions are formally categorized by frequency and the affected system-organ class.

Classification Common Side Effects Affected Systems
Common Headache, Somnolence, Fatigue, Eye Irritation, Nasal Discomfort Nervous System, Eye, Respiratory
Uncommon Eyelid oedema Eye

Local effects, particularly Eye Disorders (pain, burning, redness) and Respiratory Disorders (epistaxis, nasal discomfort), are frequently reported. Systemic effects like Headache and Somnolence (drowsiness) are also listed as common, reflecting the drug's low level of systemic absorption.

Rare but serious adverse reactions documented in regulatory information include Anaphylaxis and severe Hypersensitivity events, which involve the Immune System Disorders class. These reactions are reported at a very low frequency.

Safety considerations for specific populations exist. Caution is advised for the nasal spray formulation in patients with renal impairment during prolonged treatment due to the potential for increased drug exposure. The safety and effectiveness of the nasal spray have not been established for children under 12 years of age.

Safety-related constraints include the note that accidental oral intake of the nasal spray may lead to sedation. The eye drop formulation contains the preservative benzalkonium chloride, which necessitates that soft contact lenses be removed before administration.

Advertisements

Overdose and Emergency Response

The official regulatory profile for Levocabastine overdose addresses risks primarily associated with accidental ingestion of the topical formulation, rather than excessive routine use.

Documented Overdose Manifestations

Overdose following the accidental intake of the nasal spray contents may lead to documented systemic manifestations, the primary clinical sign explicitly identified being sedation. This effect is a recognized outcome of acute, high-level systemic exposure to the active ingredient. Regulatory information notes that no specific experience with overdosage has been formally documented for the ophthalmic suspension formulation (eye drops).

When to Seek Urgent Medical Help

In the event of a suspected overdose, including any accidental ingestion of the bottle contents, it is mandated that immediate medical attention be sought. The official procedure requires contacting a regional Poison Control Centre for expert management and guidance. This requirement applies to any suspected deviation from standard topical application leading to potential systemic effects.

Officially Described Management

Treatment of an overdosage must include general supportive measures. Furthermore, regulatory guidance specifies a procedural step to aid elimination: following accidental ingestion, the patient should be advised to drink plenty of non-alcoholic fluids. This action is intended to accelerate the renal elimination of the levocabastine compound from the body. The official labels reviewed do not document the existence of a specific antidote or set monitoring requirements for overdose scenarios.

Advertisements

Therapeutic Uses of Реактин

Реактин is commonly used for the symptomatic treatment of allergic conjunctivitis and rhinitis. It is applied across therapeutic domains where short-term symptomatic assistance is needed for conditions associated with acute or disruptive episodes to help ease the overall symptom burden. The primary indications encompass seasonal allergic conjunctivitis and allergic rhinitis (including seasonal and perennial presentations).

Relief of Allergic Eye Symptoms

The medication is specifically relevant for managing symptoms of allergic conjunctivitis that create noticeable physiological strain, such as itching, redness, and excessive tearing. Реактин provides supportive relief that helps patients cope more steadily with these difficult ocular episodes and may assist with maintaining functional stability.

Quick Fact: Relevant for Ocular Itching Symptoms

Management of Allergic Nasal Symptoms

It is also applied in addressing the challenging manifestations of allergic rhinitis, including sneezing, runny nose, and inner nasal itching. This use is applied across domains where additional symptomatic support is needed, contributing to improved day-to-day comfort during symptomatic periods, particularly when groups of symptoms appear suddenly or fluctuate.

Acute Symptom Management

The primary benefit is its relevance for acute symptom management, making it useful when symptoms intensify and supportive relief is needed. It supports general well-being during symptomatic phases by supporting patients during episodes of heightened discomfort when symptoms are more noticeable and temporarily overwhelming.

Regulatory References

  1. Health Canada Product Monograph
Advertisements

Eligibility and Restrictions for Use

Eligibility for Реактин (Levocabastine)

The official eligibility profile for Levocabastine, as defined by regulatory authorities, establishes strict criteria for use based on age, specific conditions, and physiological states.

Who Must Not Use the Medicine (Contraindications):

Category Restriction
Hypersensitivity Contraindicated in persons with a known allergy to levocabastine or any of the formulation's inactive components.
Soft Contact Lenses Use of the ophthalmic suspension is contraindicated while wearing soft contact lenses.
Age (Infants) Absolutely contraindicated in infants and children under 1 year of age, per some regulatory guidelines.

Age-Related Eligibility Rules:

Levocabastine is approved for use in adults and adolescents 12 years of age and older. Use is generally not recommended or not established for safety and efficacy in children under 12 years or in older adults (over 65 years).

Special Population Restrictions:

Use is not recommended for women who are pregnant or breastfeeding due to limited data and the excretion of levocabastine into breast milk. Additionally, caution should be exercised and potential dose reduction considered for the nasal spray formulation in patients with severe renal impairment during prolonged treatment.

Advertisements

What should I know about interactions with other medicines?

Interactions with other medicines and products

The interaction profile of topical Levocabastine is strictly defined by its low systemic plasma concentrations following application, which regulatory bodies cite as the reason significant systemic drug-drug interactions are unlikely. The overall structure of the official profile is therefore limited to local pharmacokinetic concerns and clearance pathway notes.


Official Interaction Statements

  • The nasal decongestant oxymetazoline may transiently reduce the absorption of levocabastine nasal spray (a local pharmacokinetic interaction).
  • Studies with the CYP3A4 inhibitors ketoconazole and erythromycin confirmed no impact on the pharmacokinetics of levocabastine.
  • Formal psychomotor performance studies found no significant potentiation of the effects of alcohol when the nasal spray was used at normal dosages.

Interaction-Related Restrictions

The ophthalmic suspension is contraindicated for use while wearing soft contact lenses due to a restriction related to the preservative benzalkonium chloride.


Population-Specific Caution

Caution is mandated for patients with renal impairment because the drug is predominantly cleared by the kidneys. Reduced clearance in this population results in a documented increase in systemic exposure (AUC increased by approximately 56%), which is a pharmacokinetic consideration.

Advertisements

Mechanism of Action

Реактин, which is known chemically as Chloropyramine, is classified as a first-generation Histamine H1 receptor antagonist.

Its primary biological target is the Histamine H1 receptor (H1R), a G protein-coupled receptor found in various tissues, including smooth muscle, vascular endothelium, and the central nervous system. Chloropyramine functions as a competitive, reversible antagonist at this receptor site, physically occupying the binding pocket and preventing the endogenous ligand, histamine, from binding and initiating its signal transduction cascade.

At the cellular level, H1R activation typically couples to the Gq/11 protein family, triggering the intracellular pathways involving Phospholipase C (PLC). This enzyme hydrolyzes phosphatidylinositol 4,5-bisphosphate (PIP2 ) into the second messengers Inositol triphosphate (IP3 ) and Diacylglycerol (DAG). IP3 then mediates the release of intracellular Ca^2+, and DAG activates Protein Kinase C (PKC).

By blocking the H1R, Chloropyramine interrupts this Gq/11-PLC-IP3/DAG signaling pathway, thereby inhibiting the downstream cellular responses. At the system level, the blockade of H1 receptors in the peripheral vasculature and smooth muscle modulates processes such as vasodilation and increased vascular permeability by preventing histamine-mediated effects.

Advertisements

Dosage and Administration Information

How to Use Реактин (Levocabastine) — Official Administration Guidelines

Administration of Реактин is defined for its specific topical forms, focusing on precise application and adherence to the labeled schedule. The medication is available as an ophthalmic suspension (eye drops) and a nasal spray, both at a concentration of 0.05%. Its use is restricted to the Topical Ophthalmic and Topical Intranasal routes; it is not for injection or oral use.


Official Dosing and Schedule

Application Dosing Schedule Frequency Pattern
Ophthalmic One drop instilled in each affected eye. Typically twice daily (2 times/day).
Intranasal Two sprays instilled in each nostril. May be increased to 3 or 4 times daily, if needed.

Preparation and Procedural Instructions

The usage instructions mandate specific actions to ensure proper delivery of the dose. The ophthalmic suspension bottle must be shaken well before each use to uniformly disperse the active ingredient. For the nasal spray, the user should first clear the nasal passages before administration.

Population and Duration Constraints

The standard adult dosing regimen is applied for children 6 years of age and older. Use is generally constrained by duration; treatment should not be continued for more than 8 weeks and should be discontinued if no improvement is noted within three days. For the ophthalmic form, contact lenses must be removed prior to instillation and may be reinserted after 15 minutes.

Advertisements

Recent Clinical Evidence

Research Evidence / Overview of Studies for Реактин (Levocabastine)


Evidence for Use in Conditions Characterized by Episodic Ocular Manifestations (Allergic Conjunctivitis)

The research exploring the ophthalmic formulation has primarily used short-term, double-blind Randomized Controlled Trials (RCTs). These studies examined the topical application for conditions associated with acute or disruptive episodes of eye allergy. Researchers monitored changes in pre-set ocular symptom scoring systems, focusing on outcomes related to physical discomfort such as itching, redness, and tearing, and included adults, adolescents, and children in the populations studied.

The findings from these controlled settings described patterns observed in the studies, where the onset of symptomatic change, measured in minutes, was tracked after application. Trials explored the product's role during phases of heightened symptom activity. Comparative evidence against other topical antiallergic agents is limited, and studies described different patterns of outcomes when compared to these other treatments.


Evidence for Use in Conditions Marked by Fluctuating Nasal Symptoms (Allergic Rhinitis)

The nasal spray formulation was evaluated in controlled research, including RCTs and specialized Nasal Allergen Challenge models. The primary research focus examined patient-reported outcomes describing perceived discomfort, such as sneezing, nasal itching, and runny nose (rhinorrhea).

Research described patterns where symptomatic changes were observed in the studies soon after application. Data from certain longer-term trials indicated that the patterns of response remained consistent over observation periods lasting up to 16 weeks. A key scientific gap exists in the evaluation of nasal congestion. The evidence describes that research has largely focused on other symptoms, and comparative evidence is lacking for the specific effect on nasal blockage when compared directly to topical corticosteroid nasal sprays.


Scientific Gaps and Areas Where Certainty Remains Low

Research inherently has limitations, and for Levocabastine, several areas of uncertainty remain: Follow-up durations were limited for many core studies, meaning that long-term effects are not fully established. The evidence quality varies across studies, and findings were mixed when comparing Levocabastine to the effects of newer, often dual-acting, topical antiallergic agents. Research involving individuals with complex or multiple co-occurring health conditions is limited. Research does not determine whether an individual will respond similarly to the patterns observed in the clinical trial groups.

Key Studies & References

  1. WHO ATC/DDD Index: Levocabastine (R01AC02, S01GX02)
Advertisements

Frequently Asked Questions (FAQ)

Common questions about Реактин (FAQ)


Q: Can I take Реактин if I also take a pain reliever like Tylenol (acetaminophen)?

Official regulatory documents, such as the product label, do not list specific interactions between levocabastine and common pain relievers like acetaminophen. Because levocabastine is a topical medication with very low plasma concentrations in the bloodstream, the likelihood of significant systemic drug-drug interactions is generally considered unlikely.


Q: How quickly can I expect to notice the effects of Реактин?

Studies and official product information indicate that the medicine has a rapid onset of action. Patients can often expect to notice the effects within minutes following the application of the ophthalmic suspension (eye drops) or nasal spray.


Q: How long does one dose of Реактин typically last?

The duration of effect for a single application of both the eye drops and the nasal spray is reported in official documentation to last for up to 12 hours. This duration of effect is consistent with the typical twice-daily dosing regimen described in official guidelines.


Q: Is there a generic version of Реактин available?

The active ingredient in Реактин is levocabastine hydrochloride. Depending on the country, the product may be available under various trade names or as a generic version, as authorized by local regulatory bodies.


Q: Can people with liver problems use Реактин?

Regulatory labeling includes specific recommendations for patients with renal impairment (kidney problems). However, for this topical medicine, official product information typically does not specify precautions or dosage adjustments for patients who have isolated hepatic impairment (liver problems).


Q: Are there any specific foods or drinks that should be avoided when taking Реактин?

Regulatory documents do not state that specific foods or general drinks need to be avoided. Formal studies found no significant potentiation of the effects of alcohol when the nasal spray was used at its normal dosages.


Q: Does taking Реактин affect my ability to drive or operate machinery?

Official label warnings state that the medicine can affect your ability to drive or operate machinery. This is because side effects such as drowsiness (somnolence) or dizziness (vertigo) are possible. Regulatory labeling indicates caution is warranted until the user understands how the medicine affects them.


Q: Can I combine Реактин with a nasal spray for allergies?

Official documents note that the use of other topical nasal sprays, such as the nasal decongestant oxymetazoline, may cause a transient reduction in the absorption of levocabastine nasal spray. This is a local interaction, and a healthcare professional is best suited to determine the appropriate sequencing of multiple topical sprays.


Q: Does Реактин help with hives (urticaria) as well as seasonal allergies?

Regulatory indications state that this medicine is approved for the symptomatic relief of allergic rhinitis (nasal symptoms) and allergic conjunctivitis (eye symptoms). Official labeling does not list chronic idiopathic urticaria (hives) as one of the therapeutic indications for this product.


Q: What should I do if I miss a dose of Реактин?

General guidance for missed doses in multi-dose regimens involves taking the dose when remembered. If it is near the time for the next dose, official guidance often describes skipping the missed dose and proceeding with the regular schedule, rather than taking a double dose.


Q: Is the medicine available over-the-counter or only with a prescription?

The official supply category for levocabastine varies by location. In many regions, the medicine is classified as Prescription-only (Rx-only) or is subject to pharmacist control, meaning it is not generally available on open shelves.


Q: Does Реактин cause dry mouth or dry eyes?

Regulatory safety information lists dry mouth as an uncommon side effect. Additionally, common side effects include eye irritation and eye dryness associated with the use of the ophthalmic suspension.


Q: Is Реактин known to cause weight gain?

Official regulatory documents list and categorize all reported adverse reactions. Weight gain is not listed among the common, uncommon, or rare side effects associated with the use of levocabastine.


Q: How does Реактин differ from its main active metabolite?

Pharmacokinetic studies show that levocabastine is largely excreted from the body unchanged. The primary breakdown product, or metabolite, is called the acylglucuronide of levocabastine, which is formed through the metabolism of the original drug.


Q: What does the drug interaction warning about CNS depressants mean for Реактин?

This general warning pertains to the risk of combined central nervous system (CNS) depressant effects, such as increased drowsiness, when the medicine is used with other sedating substances. However, formal studies with levocabastine did not find a significant increase in the effects of alcohol (a CNS depressant) at normal topical dosages.


Q: Is it normal to feel a bit restless or agitated after taking Реактин?

The systemic side effects of levocabastine reported most frequently are typically sedating, including headache, fatigue, and somnolence (drowsiness). Restlessness or agitation are not listed among the common adverse reactions in the official safety profile.


Q: How long after stopping Реактин does it typically stay in the body?

The time it takes for a substance to be eliminated from the body is measured by its terminal elimination half-life. Official pharmacokinetic data indicates that the half-life of levocabastine is approximately 35 to 40 hours in individuals with normal kidney function.


Q: What is the risk of overdose with Реактин described in regulatory documents?

Due to its topical application and very low levels of systemic absorption into the bloodstream, the risk of a systemic overdose is considered low. Regulatory documents do note that accidental oral ingestion of the nasal spray may lead to central nervous system effects such as sedation.


Q: Does Реактин interact with blood pressure medications?

Regulatory documents do not mention specific interactions with blood pressure medications. Given that levocabastine is a topical product with low systemic absorption, the risk of clinically significant interactions with drugs that affect the cardiovascular system is generally unlikely.


Q: Is it safe to drink coffee or caffeine while taking Реактин?

Regulatory documents do not contain a specific warning against consuming coffee or caffeine while using this product. However, general caution is always advised when combining any medicine that can cause drowsiness with stimulants or other substances that act on the central nervous system.


Q: Is Реактин suitable for people who have glaucoma?

Official warnings and contraindications for levocabastine topical preparations do not list glaucoma or an increase in intraocular pressure as a specific condition that requires special precaution or exclusion.


Q: Does Реактин have any warnings related to heart conditions?

Official regulatory information does include documented rare adverse reactions that fall under the category of cardiac disorders. These can include palpitations (irregular heartbeats) and tachycardia (abnormally fast heartbeats).


Q: Can Реактин interact with supplements or herbal products?

Regulatory documents do not specifically list interactions with supplements or herbal products. Because levocabastine has low systemic absorption after topical use, significant interactions with systemically acting supplements are considered unlikely.


Q: Is the onset of action of Реактин described differently for different symptoms?

Research documents for the eye drops describe the onset of symptomatic change as being tracked 'in minutes,' while the nasal spray studies describe symptomatic changes as being observed 'soon after application.' Both descriptions indicate a rapid effect.

Advertisements

How should Реактин be stored and disposed of?

How to Store and Dispose of Реактин?

Official regulatory documents define the storage and handling requirements for this medicine to ensure its stability and safe disposal.

Storage Condition Requirement
Temperature Store at controlled room temperature, 20 C to 25 C (68 F to 77 F).
Protection Keep in the original container to protect from moisture; keep the bottle tightly closed.
Handling Do not allow the medicine to freeze.
Access Keep this and all medicines out of the reach of children.

For disposal, the medicine must be managed according to local community environmental procedures for non-hazardous solid waste. Do not dispose of this product by flushing it down a toilet or pouring it down a sink. If the medicine is supplied with sharps (e.g., needles or syringes), these must be placed immediately into an FDA-cleared sharps disposal container after use.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Реактин found in:

A-Z Index: